Deciding which is causing a symptom change is one of the biggest challenges in managing ABPA and asthma together, since the two conditions often overlap and interact.
Here’s a breakdown to help you tell which condition might be driving your symptoms — though in many cases, they contribute together:
🧭 ABPA vs Asthma: Symptom Clues
| Symptom | More Likely ABPA | More Likely Asthma |
|---|---|---|
| Increased sputum / mucus plugging | ✅ Thick, sticky, brownish mucus common in ABPA | ❌ Asthma usually has dry cough, not much mucus |
| Sudden worsening after steroid reduction | ✅ Flare of ABPA likely | ❌ Asthma usually responds to inhalers unless severe |
| Persistent wheeze despite good inhaler use | ✅ Could suggest ABPA inflammation or mucus | ✅ Asthma too, but should improve with bronchodilators |
| Raised total IgE or eosinophils | ✅ Strong ABPA clue | ✅ Can happen in asthma too, but less extreme |
| Fever, malaise, or feeling ‘infected’ | ✅ Possible in ABPA flares | ❌ Not typical in asthma |
| Crackles or signs on chest exam | ✅ More common in ABPA with bronchiectasis | ❌ Asthma usually has wheeze, not crackles |
| Daily productive cough | ✅ Common in ABPA and bronchiectasis | ❌ Asthma usually has dry, episodic cough |
🧪 How Doctors Distinguish Them
-
Blood tests: Total IgE, eosinophils, Aspergillus-specific IgE
-
Sputum cultures: To check for Aspergillus or secondary infection
-
Spirometry: Looks for reversible airflow obstruction (asthma)
-
Chest CT scan: Shows mucus plugging, central bronchiectasis (ABPA)
-
Steroid response test: Asthma often improves rapidly; ABPA needs longer or higher doses
🔄 Important: They Often Coexist
-
Many people with ABPA have asthma first.
-
ABPA may worsen asthma symptoms by causing inflammation, mucus plugging, and airway damage.
-
Treating ABPA (with steroids, antifungals, or omalizumab) often improves asthma control.
✅ What You Can Do
-
Keep a symptom diary: track mucus, breathlessness, triggers, and response to inhalers or steroids.
-
Ask your care team to help you track your IgE and eosinophils over time.
-
If you’re on biologics (e.g., omalizumab), monitor exacerbation frequency and inhaler needs.
Share this post
Latest News posts
Nontuberculous Mycobacteria (NTM–MAC) and Aspergillosis
March 10, 2026
Asthma and Aspergillosis
March 9, 2026
Weekly Aspergillosis Research Update – Week 10, 2026
March 9, 2026
Bronchiectasis in Aspergillosis Patients
March 6, 2026
Damp & Mould Health Evidence Monitor: 4 March 2026
March 4, 2026
Weeks 6–7 Aspergillosis Literature Update
March 3, 2026
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- Blood Tests
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Other
- Other Forms Aspergillosis
- Patient Research
- Pets & Animals
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Specialists
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
